An ethical analysis of UK drug policy as an example of a criminal justice approach to drugs: a commentary on the short film Putting UK Drug Policy into Focus. [PDF]
Holland A.
europepmc +1 more source
Harm Minimisation Drug Policy Implementation Qualities: Their Efficacy with Australian Needle and Syringe Program Providers and People Who Inject Drugs. [PDF]
Resiak D, Mpofu E, Rothwell R.
europepmc +1 more source
Overcoming the Nyquist Limit in Molecular Hyperspectral Imaging by Reinforcement Learning
Explorative spectral acquisition guide automatically selects informative spectral bands to optimize downstream tasks, outperforming full‐spectrum acquisition. The selected hyperspectral data are used for tasks such as unmixing and segmentation. BandOptiNet encodes selection states and outputs optimal bands to guide spectral acquisition. Recent advances
Xiaobin Tang +4 more
wiley +1 more source
Revisiting Afghanistan's Drug Policy: A Policy Analysis of Eradication, Harm Reduction, and Economic Dependencies. [PDF]
Azizi MQ +8 more
europepmc +1 more source
Harm Reduction and Moral Desert in the Context of Drug Policy. [PDF]
Porter LB.
europepmc +1 more source
Abstinence, anti-drug psychosocial care centers and therapeutic communities: pillars for reorienting the Brazilian Mental Health and Drug Policy. [PDF]
Weber CA +3 more
europepmc +1 more source
Materials informatics and autonomous experimentation are transforming the discovery of organic molecular crystals. This review presents an integrated molecule–crystal–function–optimization workflow combining machine learning, crystal structure prediction, and Bayesian optimization with robotic platforms.
Takuya Taniguchi +2 more
wiley +1 more source
Raising a Public Health Concern: Women Overlooked in UK Drug Policy and Disadvantaged in Mixed-Gender Community Services. [PDF]
Page S +4 more
europepmc +1 more source
Impact of China's zero mark-up drug policy on drug cost of NCDs' outpatients: an interrupted time series analysis. [PDF]
Du J +7 more
europepmc +1 more source
Current Standards of Monitoring Models in Healthcare Settings
AI/ML‐enabled medical devices are entering clinical practice faster than monitoring standards mature. This review highlights gaps in postmarket surveillance, limited use of predetermined change‐control plans, and the need for ongoing performance tracking, drift detection, explainability, and workflow‐aware governance to support safer, more reliable ...
Alan Kay +5 more
wiley +1 more source

